ArticleJournal of pathology informatics2025
Efficient merging and validation of deep learning-based nuclei segmentations in H&E slides from multiple models.
Article in Journal of pathology informatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Characterizing cellular composition in tissue samples offers fundamental insights into functional and biological processes. Understanding the abundance or lack of specific cell types, such as inflammatory cells in the context of microenvironments such as tumor can help guide disease progression and personalized medicine. Several clinical laboratory methods to characterize the cellular composition are limited by scalability and high-costs. Digitizing pathology slides and applying deep learning (DL) models have enabled efficient and cost-effective nuclei segmentation and cell type quantification; however, the DL-models are limited by their inability to segment specific cell types and specific models may be more effective than others at certain tasks. Consequently, there remains a need for methods that leverage the strengths of multiple models to efficiently integrate nuclei segmentation for various cell types. In this study, we propose a novel solution for integrating nuclei segmentation from multiple DL-methods on hematoxylin and eosin slides from 471 normal prostate samples and highlight the limitations of using a single DL-method. We validate the DL-derived cell type proportions, by comparing against estimates from a manual pathologist review and show that the integrated approach results in higher concordance over the individual models. We further validate the derived cell type proportions from the DL-methods by their ability to explain the variance of RNA gene expression. The integrated approach yields robust cell type proportions that explain the variance of the gene expression with 12% and 22% relative improvement than current state-of-the-art model and manual pathologist review, respectively. The subset of 403 genes with high explained variation (>30%) by epithelial proportion were significantly enriched for relevant biological pathways. These findings indicate that ensemble approaches to nuclei segmentation and cell-type classification may provide more accurate representations of cellular composition from digitized slides.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.